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HUM A N R A B IE S  -  Co lo rado
The first case of human rabies reported in Colorado 
since 1931 died in Fitzsimons General Hospital, Denver, 
Colorado, on April 2, 1966.
The patient was an 11-year-old girl who lived with 
her parents at Widefield, a community about 7 miles 
southeast of Colorado Springs, and who had not been 
°ut of the general area for the past year. On March 23 
she became ill with fever, sore throat, and “ runny” 
nose; the following day she was kept home from school. 
On March 25 she seemed better and returned to school, 
hut that evening she experienced severe sore throat,
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muscular pains, profuse vomiting, and she refused food 
and liquids. The same symptoms persisted on March 26 
and 27, and on March 28 the patient was taken to Ft. 
Carson where a tentative diagnosis of viral gastro­
enteritis was made. On the way home she lapsed into 
coma and later in the evening evidenced spasmodic
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E P ID E M IO L O G IC  NOTES AND R E P O R T S
HUMAN R A B IE S  -  Colorado (Continued)
contractions of the mouth muscles, severe salivation and 
convulsive seizures. She was transferred to Fitzsimons 
General Hospital in Denver on March 29 in coma, where, 
late in the afternoon, she became cyanotic and had 
respiratory failure. Mouth to mouth resuscitation being 
unsuccessful, she was placed in a respirator.
The patient expired at 6:00 p.m., April 2, and an 
autopsy was performed early. Brain material was positive 
for rabies by impression smears and by fluorescent 
antibody technique. Further laboratory studies are in 
progress but have not yet been completed.
There is no known exposure to a rabid animal in 
this case. The local health department has said there is 
some evidence that the child was bitten by a dog 10 
months ago, but there is no valid history of this and the 
animal was neither quarantined nor examined for rabies.
Two cases of animal rabies have been reported from 
El Paso County during 1966, one in a cat and one in a 
skunk. The last previous rabies reported from the County 
was in 1960 when there were three cases.
Due to the prevalence of stray dogs and cats in the 
general area of Colorado Springs, a rabies quarantine 
covering thesouthern halfof E l Paso County was declared 
early in March 1966. This quarantine has since been ex­
tended to cover the entire county; an animal vaccination 
campaign was initiated at the time quarantine was started 
in March. Stray dogs and cats are being destroyed. 
(Reported by Dr. C. S. Mollohan, Chief, Section of Epi­
demiology, Dr. R. L. Cleere, Director of Public Health, 
and Dr. M. D. Baum, Chief, Veterinary Section, Division 
of Preventive Medical Services, all of the Colorado 
State Department of Public Health.)
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S U R V E IL L A N C E  SUMMARY 
T U BE RC U LOS IS  M O RT A L IT Y  IN THE UNITED STATES, 1964
According to the final figures recently released by 
the National Center for Health Statistics, 8,303 deaths 
from tuberculosis were reported in theUnited States during 
1964 compared to 9,311 deaths in 1963. The classification 
°f the tuberculosis deaths in 1964, by form of disease 
and by sex and race of the patients, is set out in Table 1.
The decrease of 1,008 deaths from 1963 to 1964 
represents the largest annual decline (10.8 percent) in 
tuberculosis mortality recorded since 1954. The trend of 
the tuberculosis death rates from 1940 to 1964 is shown 
■n Figure 1. In 1954, the mortality rate for the United 
States, including the States of Alaska and Hawaii, was 
10.2 per 100,000 population (16,527 deaths), whereas in 
1964 the rate was 4.3 per 100,000 population (8,303 
deaths).
Much of this improvement in tuberculosis mortality 
*n the United States is attributed to the widespread use, 
since the early 1950’s, of chemotherapeutic drugs in the 
c&re and treatment of tuberculosis. Similar changes have 
been reported for many other countries throughout the 
world.
fReported by the Statistical Unit, Tuberculosis Branch, 
CDC.)
Figure 1 
T U B E R C U L O S IS  DE A TH  RA T ES  
C O N T IN E N T A L  U N IT ED  STATES 
1940 through 1964
YEARS
Table 1
Tuberculosis Mortality, United States, 1964
Color
Deaths Rates/100,000 Population
Sex
Respiratory Other Forms Total Respiratory Other Forms Total
"'hite
Male 4,292 236 4,528 5.2 0.3 5.5
female 1,419 145 1,564 1.6 0.2 1.8
Total 5,711 381 6,092 3.4 0.2 3.6
N°n-white
Male 1,371 156 1,527 12.5 1.4 13.9
Female 564 120 684 4.9 1.0 5.9
Total 1,935 276 2,211 8.6 1.2 9.8
^  Races
Male 5,663 392 6,055 6.0 0.4 6.4
Fetnale 1,983 265 2,248 2.0 0.3 2.3
Total 7,646 657 8,303 4.0 0.3 4.3
136 Morbidity and Mortality Weekly Report APRIL  23, W66
RECOM MENDATIONS O F  THE P U B L IC  HEA LTH  SE R V IC E  ADV ISORY 
COMMITTEE ON IMMUNIZATION P R A C T IC E
At its meeting of February 18, 1966, the Public Health Service Advisory Com­
mittee on Immunization Practice issued two statements. The first deals with measles 
vaccines and is a revision of the initial recommendations which appeared in the MMWR, 
Vol. 11^ , No. 7 (February 20, 1965) and No. 36 (September 11, 1965). The second state­
ment deals with the current status of methodology in the prevention of transfusion- 
associated hepatitis.
I. MEASLES V A C C IN E S - S T A T U S  AND RECOM M ENDAT IONS F O R  USE
Highly effective, safe vaccines are available for 
eliminating measles in the United States. Virtually all 
children will at sometime have clinically evident measles 
unless protected by vaccine. Measles is often a severe 
disease and is of particular concern because of frequent 
complications including broncho-pneumonia, middle ear 
infection and encephalitis. Moreover, the encephalitis 
which follows measles approximately once per 1,000 
cases often results in permanent brain damage and sub­
sequent mental retardation. An average of one measles 
death occurs in every 10,000 cases.
All susceptible children by virtue of not having had 
natural measles or measles vaccine should be immunized. 
Programs directed toward vaccinating children at about 
one year of age should be established by all communities. 
Also of particular importance is the immunization of 
susceptible children entering nursery school, kindergarten 
and elementary school, since they are often responsible 
for transmission of measles to other children in the 
community.
A. L ive  Attenuated Measles V irus Vacc ines  (Edmonston 
and Schwarz Strains)
Live attenuated measles virus vaccines prepared from 
the Edmonston strain or Schwarz (further attenuated) 
strain are available for use in the United States. The 
Edmonston strain is propagated in either chick embryo or 
canine kidney cell cultures and may be given alone or 
simultaneously with Measles Immune Globulin according 
to manufacturers’ directions. The Schwarz strain is 
prepared only in chick embryo cell culture and is suitable 
for administration without Measles Immune Globulin. The 
live attenuated measles virus vaccines produce a mild or 
inapparent, non-communicable infection. Fifteen percent 
of those receiving either Edmonston strain with Measles 
Immune Globulin, or Schwarz strain, may experience fever
of 103°F (rectal) or greater, beginning about the sixth day 
and lasting no longer than five days. Edmonston strain 
alone may have about twice the frequency of such re­
sponses. However, the great majority of reports indicate 
that even children with high fever experience relatively 
little discomfort or minimal toxicity and reactions often 
go unnoticed by the parents.
An antibody response develops in virtually all 
susceptible children given live attenuated measles virus 
vaccines. The level and persistence of antibody in d u c e d  
by Edmonston strain administered alone is similar to that 
seen following regular measles. Antibody titers a t t a in e d  
following Edmonston strain with Measles Immune Globulin 
or following Schwarz strain are slightly lower. H o w e v e r , 
with a l l  three vaccine schedules, protection a g a in s t  
naturally occurring measles appears to be long lasting-
On the basis o f  experience with more than 10 m illi°n 
doses administered in the United States, live a t t e n u a te d  
measles virus vaccine appears to be one of the s a f e s t  
immunizing agents in use. To date, serious reactions 
associated with the live attenuated measles virus vac­
cines have been very rare. In some few instances, febrile 
convulsions without known sequelae, have been recorded.
B. Inactivated Measles V irus Vacc ines
Inactivated vaccines derived from Edmonston strain 
measles virus and prepared in either chick embryo or 
monkey kidney cell cultures are available. These vac­
cines are administered in a three dose schedule at month­
ly intervals with subsequent boosters. Reactions are not 
more frequent than after administration of diphtheria and 
tetanus toxoids.
Following the primary immunization with i n a c t i v a t e d  
measles virus vaccines, the protection achieved has been
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satisfactory for the first few months, but has been shown 
to decline rapidly thereafter. In view of the greater effica­
cy and the safety of live attenuated measles virus vac­
cines, inactivated vaccines are not recommended except 
in those instances where the use of live vaccines is 
contraindicated.
Combined schedules employing inactivated vaccines 
followed by live vaccines have been used (Table 2). 
However, there are not sufficient advantages to recom­
mend the use of these schedules; and, furthermore, there 
have been preliminary observations of untoward local 
tissue reactions when live attenuated measles virus 
vaccines have been administered to individuals previously 
immunized with inactivated measles vaccines.
C. Recommendations for Vacc ine  Use
1) Age
Vaccine is indicated primarily for children who have 
not had measles. For maximum efficacy, live attenuated 
measles virus vaccines should be administered to those 
at least 12 months of age. However, they may be given to 
infants 9-12 months of age with the realization that there 
may be a s ligh t reduction in efficacy, particularly if 
Measles Immune Globulin is administered with the vaccine. 
Vaccination of adults at the present time is rarely nec­
essary because most indiv iduals are serologically immune 
by age 15. Limited data indicate that in the adult, reac­
tions to vaccine are no more common than in children.
2) High R isk  Groups
Immunization against measles is particularly impor­
tant for children with chronic illnesses such as heart 
disease, cystic fibrosis, and chronic pulmonary diseases 
and, indeed, for any individual prone to serious compli­
cations following natural measles.
3) Prevention of Natural Measles Fo l low ing  Exposure
If administered up to and including the day of expo­
sure to natural measles, live attentuated measles virus 
vaccines are usually effective in preventing disease. 
Limited studies reported to date indicate, however, that 
there is no protection conferred by the vaccines when 
given at longer intervals following exposure.
Community Immunizat ion Programs
1) Ongoing Programs
Universal immunization as part of good health care 
should be accomplished through routine and intensive 
Programs conducted in physicians’ offices and public 
health c lin ics . Programs aimed at immunizing children at 
about one year of age should be established by all com­
munities. In addition, susceptible children entering
nursery school,kindergarten and elementary school should 
receive vaccine because of their particular role in com­
munity spread of natural measles.
2) Community-wide Mass Programs
Mass immunization programs may be useful to supple­
ment the ongoing administration of live attenuated measles 
virus vaccine in communities or segments of communities 
in which the proportion of individuals so protected is 
known to be low. However, the following points should 
be considered in a community-wide mass immunization 
program:
a. The active cooperation of as many physicians as 
possible in addition to the official health agencies 
normally concerned with the care of children is important.
b. Since live attenuated measles virus vaccines are 
administered parenterally, an adequate number of medical 
and nursing personnel are required.
c. Despite the acknowledged high incidence of 
measles and its frequent, serious complications, substan­
tial effort may be required to achieve complete community 
support.
d. Since measles vaccine is contraindicated in some 
children, preliminary screening to identify such individuals 
is desirable in mass measles immunization programs and 
should be provided where capability exists.
e. Although a number of children may have febrile 
reactions following live attenuated measles virus vac­
cine, experience in community-wide campaigns and in 
private medical practice indicates that only a small 
fraction of these reactions requires medical attention. 
Parents should be made aware of the reasonable expec­
tations of such reactions in order that no undue concern 
develops after the program is underway.
3) Control of Measles Ep idem ics
Measles surveillance can pinpoint potential out­
breaks in ample time to institute effective control. 
Several studies have shown that measles epidemics can 
be curtailed or halted by vaccination of selected groups 
of children in a community, particularly the susceptibles 
in nursery school, kindergarten and the first two or three 
grades of elementary school. However, once measles is 
widely disseminated in a community, it may be necessary 
to immunize susceptible children of all ages in order to 
alter the course of an epidemic.
E. Immunizat ion Schedules
Recommended immunization schedules are shown in 
Table 2, page 139.
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F . P recau tions  in the Use of L ive  Attenuated Measles 
V irus Vacc ines
1) Severe Febrile  I l lnesses
Vaccination should be postponed.
2) Tubercu losis
Exacerbations of tuberculosis by natural measles 
infection have been noted, and by analogy might theoreti­
cally accompany infection with live attenuated measles 
viruses. (An observed basis of similarity between the 
natural and attenuated viruses is their ability to suppress 
tuberculin skin test positivity.) Therefore, individuals 
with active tuberculosis should be under treatment when 
live attenuated measles virus vaccines are given. A l­
though tuberculin skin testing prior to age one year is 
desirable as part of ideal health care for individual 
patients, it should not be a routine prerequisite in com­
munity measles immunization programs. For children 
included in these programs, the risk from natural measles 
often far outweighs the theoretical hazards of possible 
exacerbation of undiagnosed tuberculosis.
3) Recent Immune Globu lin  Administration
Following the administration of more than 0.01 ml/ 
pound of immune globulin, immunization should be deferred 
from six weeks to three months depending on the relative 
dosage administered, since the persistence of measles 
antibody in the globulin may interfere with response to 
to the vaccine.
4) Marked Hypersens it iv ity to Vacc ine  Components
Measles vaccines produced in chick embryo cell 
cultures should not be given to children sensitive to egg 
protein as indicated by their inability to eat eggs or egg 
products. Similarly, vaccines produced in canine cell cul­
tures should not be administered to children highly 
sensitive to dog hair or dog dander.
5) Concurrent Use of L ive  Attenuated Measles V irus V ac ­
c ines With Other L ive  V irus Vacc ines
Theoretical possibilities of superimposed reactions 
and suppressed antibody responses have led to general 
acceptance of the desirability of not administering more 
than one live antigen at a time when they can efficiently 
bo given separately. Ideally, primary oral poliomyelitis 
immunization should be completed prior to the time indi­
cated for measles vaccine and the two antigens separated
by at least one month. Since smallpox and measles vac­
cines may each produce febrile reactions, similarly, there 
is merit in administering them at different times. When 
combined administration is elected for reasons of patient 
inaccessibility or threat of concimitant exposures, 
current information from field investigations would s u g g e s t  
that results comparable to those following separate ad­
ministration can be anticipated.
G. Contra ind ica t ions  to Use of L ive  Attenuated Measles 
V irus Vacc ines
If measles immunization is indicated for persons with 
diagnoses listed in the following three groups, in a c t iv a te d  
measles vaccine should be used.
1) Leukem ia , Lympomas and Other Genera l ized  Malig­
nancies
Although there are no reports of unusual complications 
of vaccine administration in children with severe under­
lying diseases other than leukemia, it is conceivable on 
theoretical grounds that in such individuals, potentiation 
of the attenuated measles virus infection might occur.
2) Altered Res is tance  from Therapy with agents such as 
steroids, alkylating drugs, antimetabolites, and irradiation.
3) Pregnancy
Purely on speculative grounds, there is reluctance 
to risk fetal damage which might theoretically be related 
to attenuated measles virus infection.
H. Continued Surveil lance
Intensive surveillance of measles and its complica­
tions is needed to appraise the effectiveness of national 
immunization programs. Such surveillance activities can 
delineate failures to achieve adequate levels of protec­
tion and the definition of groups in which epidemic con­
trol programs should be instituted.
Although more than 10 million doses of m e a s le s  
vaccine have been administered in the United States, 
continuous and careful review of adverse reactions is of 
utmost importance. All serious reactions should be 
carefully evaluated and reported in detail to local and 
State health officials. The Communicable Disease C enter 
should maintain close surveillance of all such experiences-
II. P R E V E N T IO N  O F  TRANSFUSION-ASSOCIATED H EPA T IT IS
The risk of viral hepatitis following blood transfusion 
represents a serious and continuing problem. A number of 
reports indicate that the incidence of clinical hepatitis 
is greater among recipients of blood obtained from certain 
categories of donors. The risk also becomes greater as 
the number of transfusions increases. In addition, the
case-fatality rate of transfusion-associated hepatitis 
increases with advancing age.
Evidence has been advanced both for and against the 
effectiveness of immune globulin in the prophylaxis of 
transfusion-associated hepatitis. Although the adminis­
tration of immune globulin in a dose of 10 ml at the time
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°f the transfusion and again one month later has been 
reported by some investigators to be effective in reducing 
the number of cases, evidence of the efficacy of this pro­
cedure is lacking in other carefully conducted trials. In 
view of these uncertainties, existing data do not provide 
a basis for allocating supplies of immune globulin for its 
foutine administration to recipients of blood transfusions.
Several methods for lowering the incidence of trans­
fusion-associated hepatitis are available. More attention 
should be directed toward enforcement of adequate 
standards of donor quality, development of central regis­
tries for the identification of known or suspect carriers, 
and encouraging the practice of using blood and potenti­
ally icterogenic blood products only when necessary.
Table 2
IMMUNIZATION SCHEDULES FOR MEASLES VACCINES
Schedule Type of Vaccine Age
Doses* and 
Administration Comments
1 Live attenuated 
measles virus 
vaccine
(Edmonston Strain)
12** Months 
and Older
1 Although the live attenuated measles 
virus vaccine may be administered 
safely with or without Measles 
Immune Globulin, many physicians 
will wish to give the two simultane­
ously because of the lessened 
frequency of clinical reactions.
2 Live attenuated 
measles virus 
vaccine
(Edmonston Strain) 
plus Measles Immune 
Globulin
12** Months 
and Older
1 plus Measles 
Immune Globulin 
(.01 ml per lb. 
at different site 
with different 
syringe)
3 Live “ further 
attenuated” measles 
virus vaccine 
(Schwarz Strain)
12** Months 
and Older
1 Clinical reactions approximate those 
observed in schedule 2; Measles 
Itnmune Globulin is not recommended 
with this vaccine.
4 Inactivated
Vaccine
Any Age 3 (monthly 
intervals) plus a 
booster dose at 
one year
In view of the rapid fall-off in 
antibody and evidence of decreasing 
immunity following a primary immuni­
zation series, use of this vaccine is 
not recommended except for special 
groups in which live attenuated 
measles virus vaccine is contra­
indicated.
5 Inactivated vaccine 
followed by live 
attenuated measles 
virus vaccine
12 Months 
and Older
1 dose inactivated 
vaccine followed in 
1 to 3 months by 1 
dose live attenu­
ated measles virus 
vaccine
The preceding administration of 
inactivated vaccine serves to reduce 
the frequency and severity of clinical 
reactions following live attenuated 
measles virus vaccine administration. 
Local tissue reactions have been 
noted in some instances.
Under 12 
Months
3 doses inactivated 
vaccine at monthly 
intervals followed 
by 1 dose live 
attenuated measles 
virus vaccine at 12 
months or older.
‘ Manufacturers’ directions regarding volume of dose should be followed.
**May be given to infants between 9 months and 1 year with the expectation of slightly decreased efficacy especially 
‘f administered simultaneously with Measles Immune Globulin.
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CASES OF SPECIFIED NOTIFIABLE DISEASES: UNITED STATES
FOR WEEKS ENDED 
A P R IL  23, 1966 A N D  A PR IL  24, 1965 (16th W EEK )
__a-
AREA
ASEPTIC
MENINGITIS BRUCELLOSIS
ENCEPHALITIS
DIPHTHERIA
HEPATITIS ___-
Primary 
including 
unsp. cases
Post-
Infectious Serum Infectious
Both
Types
1966 1 1965 1966 1966 1965 1966 1966 1965 1966 1966 1965___ _
UNITED STATES... 20 17 6 31 30 25 10 2 695
NEW E N G LAND........... 1 _ 1 2 1 2 1 35 41
M a i n e ................ - - - - - _ _ _ _ 3 14
New Hampshire...... - - - - - - - _ _ 1 3V ermo nt .............. - - - _ _ _ _ _ 1
- - 1 2 1 1 _ _ 1 27 15Rhode Island....... 1 - - _ _ _ _ 3
Connecticut......... - - " - - 1 - - - 4 5
MIDDLE ATLANTIC...... 2 3 _ 10 10 4 14 85 124New York C i t y...... 2 - - 1 4 _ _ _ ■ 11 8 21New York, Up-State. - 2 - 4 2 1 _ _ 31 56New J e rsey.......... - - - 5 2 _ _ _ 2 19 18Pennsylvania........ “ 1 “ - 2 3 - - 1 27 29
EAST NORTH CENTRAL... 3 2 - 5 2 4 . 4 92 137- - - 3 - _ _ _ 2 30 30- - 1 _ _ 11 8Illinois............. r • 2 - - 1 - _ 4 28Michigan............ 3 - - 1 1 4 _ 2 41 60W isconsin........... “ " - - - - - - 6 11
WEST NORTH CENTRAL... - - 2 _ 1 65
Minnesota........... - - - - 1 _ 3
Iowa................. - - 1 - - _ _ _ 5 42
- - - - - - - _ _ 28 4North D a k o t a....... - - - - - _ _ _ .
- - 1 - _ _ 4
Nebraska............ - - - - - _ _ _ 1
Kansa s............... - - - - - - - - - 3 11.
SOUTH ATLANTIC....... 2 4 - 5 5 1 _ 1 1 91 61D elaware............ - - - - - - _ 1
Maryland............ - - - - 3 - _ _ _ 31 8Dist. of Columbia.. - - - - - _ _ .
Virginia............ - - - 1 - - _ _ 1 8 22- - - - - - _ _ 8 42 1 - 4 1 _ _ 5
South Carolina..... - - - - - _ 2
Georg ia.............. - - - - - - _ 1 16 2
- 3 - - 1 1 - - 15 17
EAST SOUTH CENTRAL... _ 1 1 1 1 3 1 81 38- 1 - - - - _ _ 35 8Tennessee........... - - 1 1 1 3 _ _ 17 14
- - - - - - _ _ 19 11Mississippi......... - - - - - - 1 - - 10 5
WEST SOUTH CENTRAL... 3 3 1 2 1 1 58 51Arkansas............ - - - 2 1 - _ 9 3
- - 1 - - 1 _ 10 8- 2 - - - - _ _ 1 -Te x a s ................ 3 1 - - - - - - - 38 40
M OUNTAIN............... _ 1 _ 2 1 _ 9 17 40M onta na.............. - - - - - - 9 •. ■ _ 3 2
- - - - - - 2 3
- _ » _ 1 _ 1
Colorado............ - 1 _ 2 _ _ 13
New Mexico.......... - - - - - _ _ 6 9
- - _ - - _ _ 5
U t a h ................. - - - _ ■ - _ _ 7
- - - - - - - - - 1 '
P ACIFIC ................ 9 3 1 4 8 10 _ l 10 146 138
- - _ _ _ _ 5
- - _ 1 _ _ 7
9 3 1 3 8 10 _ l 10 110 121A l a s k a ............... - - _ _ _ _ • 3
Hawaii............... - - - - - _ _ _ 4
29
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CASES OF SPECIFIED NOTIFIABLE DISEASES: UNITED STATES 
FOR WEEKS ENDED 
A PR IL  23, 1966 A N D  A P R IL  24, 1965 (16th W EEK ) - C O N T IN U E D
AREA
UNITED STATES..
ENGLAND..........
Maine...............
Hampshire.....
Vermont .............
Massachusetts.....
Rhode Island......
Connecticut........
^ » D L E  ATLANTIC .....
New York City.....
New York, Up-State
New Jersey.........
Pennsylvania......
Ea s t  NORTH CENTRAL..
Ohio................
Indiana............
Illinois...........
Michigan...........
Wisconsin..........
NORTH CENTRAL. .
Minnesota..........
Iowa..................
Missouri...........
North D a kota......
South D a kota......
Nebraska...........
Kansas..............
south a t l a n t i c ......
Delaware............
d r yland ............
Dist. of Columbia.
Virginia..........
West Virginia.....
North Carolina,... 
South Carolina.,.,
Georgia..............
pl°rida...........
E*ST s o u t h  c e n t r a l . .
Kentucky..........
Tennessee.........
Alabama............
Mississippi.......
SOUTH CENTRAL..
Arkansas........ .
Louisiana...........
Oklahoma............
Texas................
"obtain...............
Montana...........
Idaho................
do m i n g ..............
Colorado..........
New Mexico........
Arizona..............
utah...............
Nevada...............
iAclPXC.
> i n g t;;:::::::::
°regon..............
^ U f o r n i a .........
Alaska..............
»«fl.a»a<< ................
Rico..........
MEASLES (Rubeola) MENINGOCOCCAL INFECTIONS, TOTAL
POLIOMYELITIS
RUBELLATotal Paralytic
p 1 '. • Cumulative Cumulative
1966
1966 1966 1966 1965 1966 19661966 1965 1966 1965
8,514 117,800 151,426 98 1,632 1,382 - - - 6 1,792
81 1,399 28,388 1 73 70 _ . 2578 154 2,083 - 7 8 - _ _ _ 5
5 25 335 - 7 4 - _ _ _ 2
2 204 493 - 3 2 - _ _ _ 5
31 538 15,785 1 30 23 - _ _ _ 123
4 61 3,094 - 5 11 - _ _ _ 7
31 417 6,598 - 21 22 - - - - 115
651 13,786 6,368 9 176 181 _ _ . 87
228 6,948 687 1 25 27 - - _ _ 32
93 1,448 2,063 1 48 43 - _ « _ 53
77 1,473 1,102 4 51 61 - - _ _
253 3,917 2,516 3 52 50 - - - - 2
2,543 44,080 28,680 20 244 168 _ _ _ 372
484 3,750 5,893 6 67 51 - - _ _ 33
279 2,773 1,111 2 38 23 - - _ _ 166
233 8,804 1,060 3 46 43 - - _ _ 79
291 7,188 15,370 6 68 28 - _ _ _ 94
1,256 21,565 5,246 3 25 23 - - - -
390 5,505 11,626 7 87 75 _ _ . 1 126
99 1,337 369 1 22 15 - _ _ 1 12
223 3,005 6,419 1 13 2 - _ _ _ 113
56 371 1,757 - 33 37 - _ _ _
10 745 2,728 - 3 3 - _ . _ 1
- 3 63 1 3 2 - _ _ _ _
2 44 290 3 6 9 - _ _ _ _
NN NN NN 1 7 7 - - - - -
628 9,082 17,26.5 19 263 276 _ _ _ 1 139
3 120 390 - 3 3 _ _ _ _ _
66 1,375 646 2 25 26 _ _ _ _ 7
5 307 27 - 6 4 _ _ _ _
110 956 2,659 5 38 29 - _ _ _ 23
192 3,485 10,289 1 9 22 - _ _ _ 16
5 150 206 5 53 42 _ _ _
27 426 713 2 36 44 - - - _ 5
- 177 478 - 41 35 - - - 1
220 2,086 1,857 4 52 71 - - - - 88
1,262 13,296 9,706 10 139 99 _ _ _ _ 356
212 3,902 1,870 5 62 44 - - - _ 230
556 7,511 5,345 1 41 29 - - - _ 120
451 1,229 1,744 4 27 20 - - - _ 6
43 654 747 - 9 6 - - - -
1,249 13,790 21,447 15 247 224 _ _ _ 3 15
50 425 832 1 13 12 - - _ _
4 68 54 5 95 126 - - _ _
44 312 125 1 10 16 - - _ 1 _
1,151 12,985 20,436 8 129 70 - - - 2 15
635 6,548 11,868 _ 56 49 _ _ 176
123 990 2,794 - 3' 1 - - _ _ 11
41 655 1,746 - 1 7 - - . _ 3
7 89 623 - 1 2 - -, - _ 50
39 680 2,555 - 32 11 - - - _ 17
133 465 469 - 9 7 - - _ _
278 3,452 496 - 8 14 - - - _ 91
14 193 3,057 - - 5 - _ _ _ 4
- 24 128 - 2 2 - - - -
1,075 10,314 16,078 17 347 .240 _ _ _ 1 264
61 1,852 4,800 2 21 17 - - - 1 85
74 795 2,276 5 20 18 - - _ _ 20
925 7,539 7,043 9 289 198 - - . _ 141
7 58 106 1 14 4 - - _ _ 12
8 7 0 -J U85.3 - 3 . 3 - - _ _ 6 ____
89 1,485 1,052 - 2 3 - - - - 1
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CASES OF SPECIFIED NOTIFIABLE DISEASES: UNITED STATES 
FOR WEEKS ENDED 
A PR IL  23, 1966 A N D  A P R IL  24, 1965 (16th W EEK ) - C O N T IN U ED
TETANUS TULAREMIA TYPHOID
TYPHUS 
TICK- 
(Rky. Mt.
FEVER
BORNE
Spotted)
RABIES IN 
ANIMALS
1966 Cum. 1966 Cum. 1966 Cum. 1966 Cum. 1966 Cum.1966 1966 1966 1966 1966
6 34 - 47 7 83 - 9 113 1,042
- 2 - 1 - 3 _ _ 3 16
- “ - - - - - _ _ _
“ - - - - - - - _ 6
“ - - - - - - - 3 10
- 2 - 1 - - - _ _ -
- - - - - - _ _ _ _
i '“ - - - - 3 - - - -
- 5 - - 3 20 _ 1 10 103- 3 - - 3 11 - - _ -
- ■ - - - 3 - - 10 98- “ - - - 3 - _ _ _
' 2 ■ - - 3 - 1 - 5
1 3 - 12 2 15 _ _ 13 198- “ “ 3 - 6 - - . 1041 3 - 2 _ _ 7 451 1 - 5 1 2 - _ 2 15- 1 - - - 2 - - 2 17— 1 1 3 - - 2 17
1 2 - 3 1 9 - 1 25 305
“ “ ■ - - - - 4 55
" “ - - - 3 - _ 1 691 2 - 1 - 4 - _ 12 118- - - - - - - _ 5
~ - ■ - - - - - 5 33— “ ■ - 1 1 - _ _ 7
' - 2 - 1 - 1 3 18
- 8 - 6 - 15 - 6 14 181" “ - - - - - _ _ _
- - - - 5 - _ _ _
■ - - - - - _ _ -
■ “ - 2 - 6 - 2 6 122
■ - - 1 - 1 - - 3 21“ - - 2 - 2 - 3 _ _- 1 - 1 - - - _ _
“ 3 - - - - - 1 3 23
' 4 ■ " - 1 - - 2 15
1 2 - 12 - 7 _ _ 12 197
•” “ “ 2 - 1 - - 1 27
“ - - 6 - 4 - - 9 1641 2 - 4 - 2 - - 2 6
2 8 _ 11 _ 3 . 1 24 3032 2 - 9 - - - 1 _ 38
~ 3 - 1 - 1 - - 1 17
" “ - - - 1 - - 16 84
” 3 ~ 1 - 1 - - 7 164
1 1 - 1 - 6 _ _ 7 25
" “ “ - - - - - 4 6
" “ - - - - - - _ -
- - - - - - _ _ _ _
1 1 - - - 2 - _ _ 1
- - - - - - - - _ 5
- - - - - 1 - - 2 12
“ - - 1 - 3 - - _ -
“ - “ - - - - - 1 1
- 3 - 1 1 5 _ _ 5 74
“ “ - • - • - - - - _ -
- - - - - 1 - _ _ .
- 3 - 1 - 3 - - 5 74
- — - - - _ _ _
- - - - 1 1 - - - —
4 15 - - - 3 - - - 3
STREPTOCOCCAL 
SORE THROAT & 
SCARLET FEVER
1966
UNITED STATES...
NEW E N GLAND...........
Mai n e................
New Hampshire..... .
V e r m o n t ..............
Massachusetts......
Rhode Island.......
Connecticut.........
MIDDLE ATLA N T I C......
New York C i t y......
New York, Up-State.
New Jers ey..........
Pennsylvania.......
EAST NORTH CENTRAL...
Ohio.................
Indiana..............
Illinois............
Michigan. ............
Wisconsin...........
WEST NORTH CENTRAL...
Minnesota...........
Iowa.................
Missouri............
North Dakota........
South Dakota........
N ebraska............
Kansas...............
SOUTH ATLANTIC.......
Delaware............
Maryland............
Dist. of Columbia..
V irginia............
West Virginia......
North Carolina.....
South Carolina.....
Georgia..............
Florida..............
EAST SOUTH CENTRAL...
Kentucky............
Tennessee...........
A labama..............
Mississippi.........
WEST SOUTH CENTRAL...
Arkansas............
Louisiana...........
Oklahoma............
Texas................
M OUNTAIN...............
Montana..............
Idaho................
Wyoming..............
Colorado............
New Mexico..........
Arizona..............
U t a h.................
Nevada...............
P ACIFIC................
Washington..........
Oregon...............
California..........
A l aska...............
Hawaii...............
Puerto Rico...........
10,808
1,677
86
25 
4
295
124
1,143
413
22
326
NN
65
1,307
177
275
177
281
397
325
14
160
16
76
26 
7
26
1,421
32
232
2
440
288
19
116
3
289
1,879
449
1,241
112
77
1,023
2
3
74
944
1,408
84
156
16
667
249
81
155
1,355
450
35
763
59
48
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No. Table 4. DEATHS IN  122 UNITED STATES CITIES FOR WEEK ENDED A P R IL  23, 1966
(By place of occurrence and week of filing certificate. Excludes fetal deaths)
All Causes Pneumonia 
and 
Influenza 
All Ages
Under 
1 year 
All 
Causes
All
Ages
65 years 
and over
733 458 27 31
215 122 5 5
32 21 3 1
30 18 - -
30 25 - -
61 39 2 6
26 17 2 1
17 12 1 -
27 13 - 3
54 33 1 -
69 39 7 6
8 8 - -
63 45 5 3
30 20 - 1
71 46 1 5
3,682 2,240 191 157
41 22 3 7
44 26 - -
195 113 10 11
51 30 2 2
37 23 1 2
42 28 5 -
68 46 4 7
74 41 5 3
1,871 1,150 100 59
37 18 1 -
572 338 16 36
226 131 9 11
60 44 6 3
114 74 13 6
23 9 - 2
46 29 2 -
70 52 2 3
54 25 4 2
30 23 5 1
27 18 3 2
2,782 1,556 135 155
71 44 - 1
52 27 1 2
878 484 51 61
142 92 5 7
201 107 2 10
127 69 5 6
81 47 1 6
369 206 24 15
32 17 4 4
50 32 2 1
43 25 4 3
39 19 6 2
58 34 7 3
199 99 8 14
33 17 - 2
111 64 5 8
32 17 1 -
39 18 4 6
30 18 3 -
121 71 2 3
74 49 - 1
942 614 50 46
51 40 2 1
24 16 1 1
53 30 5 5
135
33
92
23
6
2
1
1
132
70
89
49
4
3
7
5
289 167 12 14
102 72 6 6
53 36 9 5
Area
All Causes
All
Ages
65 years 
and over
Pneumonia 
and 
Influenza 
All Ages
Under 
1 year 
All 
Causes
^  ENGLAND:
B°ston, Mass.------
B r i d g e p o r t, Conn.--
Cambridge, Mass.---
Pall River, Mass.-- 
Hartford, Conn.----
Lowell, Mass.------
Lynn, Mass.--------
New Bedford, Mass.-
New Haven, Conn.---
Providence, R. I.-- 
Sonterville, Mass.-- 
Springfield, Mass.-
Waterbury, Conn.---
Worcester, Mass.---
^ D L E  ATLANTIC:
Albany, N. Y.--------
Allentown, Pa.-----
Buffalo, N. Y.-----
Camden, N. J.------
Elizabeth, N. J.---
Erie, pa .-----------
Jersey City, N. J.-
Newark, N. J.-------
New York City, N. Y
Paterson, N. J.----
Philadelphia, Pa.—
Pittsburgh, Pa.-----
heading, Pa.-------
Rochester, N. Y.*--- 
Schenectady, N. Y.-
Scranton, Pa.-------
Syracuse, N. Y.----
Benton, N. J.-----
Utica, N. Y.--------
honkers, N. Y.------
NORTH CENTRAL:
Akron, Ohio........ .
Canton, Ohio--------
Chicago, 1 1 1 . .......
Cincinnati, Ohio---
Cleveland, Ohio----
Columbus, Ohio..... .
Dayton, Ohio....... .
Detroit, Mich...... .
Evansville, Ind.---
EHnt, Mich........ .
Eort Wayne, Ind.---
Gary, Ind............
Crand Rapids, Mich.- 
*ndianapolis, Ind.--
^ dison, Wis....... .
Milwaukee, Wis.----
Peoria, III.-—----
Rockford, 111.......
South Bend, Ind.---
^°ledo, Ohio....... .
°ungstown, Ohio---
NORTH CENTRAL:
es Moines, Iowa---
“uluth, Minn....... .
Kansas City, Kans.--
^nsas City, Mo.---
Lincoln, Nebr...... .
Minneapolis, Minn.*--
rnaha, Nebr........ .
Louis, Mo.------
Paul, Minn.-----
ichita, Kans...... -
SOUTH ATLANTIC:
Atlanta, Ga.-----------
Baltimore, M d.--------
Charlotte, N. C.------
Jacksonville, Fla.---
Miami, Fla.............
Norfolk, Va . -----------
Richmond, Va.----------
Savannah, Ga.----------
St. Petersburg, Fla.-
Tampa, Fla.------------
Washington, D. C . -----
Wilmington, Del.------
EAST SOUTH CENTRAL:
Birmingham, Ala.------
Chattanooga, Tenn.---
Knoxville, Tenn.------
Louisville, Ky.-------
Memphis, Tenn.--------
Mobile, Ala.----------
Montgomery, Ala.-----
Nashville, Tenn.-----
WEST SOUTH CENTRAL:
Austin, Tex.-----------
Baton Rouge, La.-----
Corpus Christi, Tex.-
Dallas, Tex.----------
El Paso, Tex.---------
Fort Worth, Tex.-----
Houston, Tex.------------
Little Rock, Ark.-----
New Orleans, La.-------
Oklahoma City, Okla.--
San Antonio, Tex.------
Shreveport, La.--------
Tulsa, Okla.------------
MOUNTAIN:
Albuquerque, N. Mex.—  
Colorado Springs, Colo
Denver, Colo.-----------
Ogden, Utah-------------
Phoenix, Ariz.----------
Pueblo, Colo.-----------
Salt Lake City, Utah- • 
Tucson, Ariz.-----------
PACIFIC:
Berkeley, Calif;*-------
Fresno, Calif.----------
Glendale, Calif.-------
Honolulu, Hawaii-------
Long Beach, Calif.----
Los Angeles, Calif.---
Oakland, Ca l i f .--------
Pasadena, Calif.-------
Portland, Oreg.--------
Sacramento, Calif.----
San Diego, Calif.----- 
San Francisco, Calif.-
San Jose, Calif.---- —
Seattle, Wash.-------—
Spokane, Wash.---------
Tacoma, Wash.----- -
1,290
129
281
58 
73 
91 
54 
93 
33
101
93
233
51
612
99
53 
45
121
115
37
45
97
1,043
30 
37
31 
143
26
76 
175
59 
182
82
86
54 
62
444
43
16
124
13
115
21
54
58
1,664
18
60 
29 
40
77 
448
99
49
134
59
98 
213
37
190
64
49
704
63
157
28
33
47 
26
49
14
84 
65
113
25
317
44
26 
26 
71 
62 
21 
23 
44
563
20
17
20
85 
13
48 
79 
32 
85
43
50 
32 
39
253
23
9
79
9
59
15 
30 
29
1,000
12
32 
22
16
44 
281
50
33 
75
37 
48
125
22
114
51
38
60
2
15
3
2
3 
2 
1
7 
11 
12
2
40
1
5 
1
17
8 
1
4
3
55
5 
2 
1
6
4
3 
76
4 
2 
3
5
7
25
8 
1 
9
3
1
1
2
50
1
3 
13
1
4 
1 
2
5 
1
12
16
72
11
12
3 
5
4 
2
5 
1
4
21
4
30
5 
5 
2 
3
16
65
1
2
9
3
3
9
8
11
6
6
3
4
23
5 
1 
4
7
1
4
1
79
6
6
25
2
2
9
2
6
6
3
7
Total 13,192 7,705 631 658
stimate - based on average percent of divisional total.
Cumulative Totals 
including reported corrections for previous weeks
All Causes, All A g e s ----- ------------------------  212,971
All Causes, Age 65 and over------------------- 124,032
Pneumonia and Influenza, All Ages---------------- 10,541
All Causes, Under 1 Year of A ge------------------  10,801
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IN T E R N A T IO N A L  N O T E S - Q U A R A N T IN E  MEASURES
Immunization information for International Travel—1965-66 
edition—Public Health Service Publication No. 381).
Page 15—Plague
Paragraph 2, Line 4
Delete  “ The complete standard course need not be 
repeated at that time.”
Insert “ Anyone who has had a previous vaccination 
against plague should receive two injections 
spaced at a thirty day interval. Children may 
be vaccinated against plague at the age of 
three months.”
T H E  M O R B I D I T Y  A N D  M O R T A L I T Y  W E E K L Y  R E P O R T ,  W I T H  A C I R C U L A ­
T I O N  O F  1 5 . 6 0 0 .  I S  P U B L I S H E D  A T  T H E  C O M M U N I C A B L E  DI SEASE .  
C E N T E R .  A T L A N T A ,  G E O R G I A .
D A V I D  J .  S E N C E R .
A . D .  L A N G M U I R .  M.D- 
I D A  L .  S H E R M A N .  M.5*
C H I E F .  C O M M U N I C A B L E  D I S E A S E  C E N T E R  
C H I E F ,  E P I D E M I O L O G Y  B R A N C H  
A C T I N G  C H I E F ,  S T A T I S T I C S  S E C T I O N
E D I T O R :  M M W R d . j . m . Ma c k e n z i e , m . b .. 
F .  R .  C .  P .  E .
I N A D D I T I O N  T O  T H E  E S T A B L I S H E D  P R O C E D U R E S  F O R  R E P O R T I N G  
M O R B I D I T Y  A N D  M O R T A L I T Y .  T H E  C O M M U N I C A B L E  D I S E A S E  C E N T E R  
W E L C O M E S  A C C O U N T S  O F  I N T E R E S T I N G  O U T B R E A K S  O R  C A S E  I N V E S ­
T I G A T I O N S  W H I C H  A R E  O F  C U R R E N T  I N T E R E S T  T O  H E A L T H  O F F I C I A L ^  
A N D  W H I C H  A R E  D I R E C T L Y  R E L A T E D  T O  T H E  C O N T R O L  
C O M M U N I C A B L E  D I S E A S E S .  S U C H  C O M M U N I C A T I O N S  S H O U L D  
A D D R E S S E D  T O :
T H E  E D I T O R  
M O R B I D I T Y  A N D  M O R T A L I T Y  W E E K L Y  R E P O R T  
C O M M U N I C A B L E  D I S E A S E  C E N T E R  
A T L A N T A .  G E O R G I A  3 0 3 3 3
N O T E :  T H E  D A T A  I N T H I S  R E P O R T  A R E  P R O V I S I O N A L  A N D  
B A S E D  O N  W E E K L Y  T E L E G R A M S  T O  T H E  C D C  B Y  T H E  I N D I V I D U * ~  
S T A T E  H E A L T H  D E P A R T M E N T S .  T H E  R E P O R T I N G  W E E K  C O N C L U D E  
O N  S A T U R D A Y :  C O M P I L E D  D A T A  O N  A N A T I O N  A L  B A SI S A R E  R E L E A S E  
O N  T H E  S U C C E E D I N G  F R I D A Y .
